JAK Inhibitors: Safety and Surveillance

This chapter delves into the safety concerns surrounding JAK inhibitors, emphasizing the need for more comprehensive data from upcoming clinical trials. The discussion balances initial enthusiasm with emerging risks, particularly in relation to cardiovascular health and cancer, highlighting the crucial need for ongoing research in this area.